Devyser Diagnostics AB (publ) (DVYSR.ST)

SEK 117.0

(0.0%)

Gross Profit Summary of Devyser Diagnostics AB (publ)

Devyser Diagnostics AB (publ)'s latest annual gross profit in 2023 was 148.1 Million SEK , up 40.02% from previous year.
Devyser Diagnostics AB (publ)'s latest quarterly gross profit in 2024 Q1 was 41.9 Million SEK , up 1.95% from previous quarter.
Devyser Diagnostics AB (publ) reported a annual gross profit of 105.76 Million SEK in annual gross profit 2022, up 41.67% from previous year.
Devyser Diagnostics AB (publ) reported a annual gross profit of 74.66 Million SEK in annual gross profit 2021, up 31.79% from previous year.
Devyser Diagnostics AB (publ) reported a quarterly gross profit of 35.2 Million SEK for 2024 Q3, down -17.18% from previous quarter.
Devyser Diagnostics AB (publ) reported a quarterly gross profit of 41.9 Million SEK for 2024 Q1, up 1.95% from previous quarter.

Annual Gross Profit Chart of Devyser Diagnostics AB (publ) (2023 - 2018)

Historical Annual Gross Profit of Devyser Diagnostics AB (publ) (2023 - 2018)

Year	Gross Profit	Gross Profit Growth
2023	148.1 Million SEK	40.02%
2022	105.76 Million SEK	41.67%
2021	74.66 Million SEK	31.79%
2020	56.64 Million SEK	8.37%
2019	52.27 Million SEK	50.21%
2018	34.8 Million SEK	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	42.5 Million SEK	1.43%
2024 Q3	35.2 Million SEK	-17.18%
2024 Q1	41.9 Million SEK	1.95%
2023 FY	148.1 Million SEK	40.02%
2023 Q1	33.7 Million SEK	23.13%
2023 Q4	41.1 Million SEK	0.74%
2023 Q3	40.8 Million SEK	27.9%
2023 Q2	31.9 Million SEK	-5.34%
2022 Q1	25.8 Million SEK	35.36%
2022 FY	105.76 Million SEK	41.67%
2022 Q3	27.2 Million SEK	6.67%
2022 Q4	27.36 Million SEK	0.62%
2022 Q2	25.5 Million SEK	-1.16%
2021 Q4	19.06 Million SEK	0.0%
2021 FY	74.66 Million SEK	31.79%
2020 FY	56.64 Million SEK	8.37%
2019 FY	52.27 Million SEK	50.21%
2018 FY	34.8 Million SEK	0.0%

Peer Gross Profit Comparison of Devyser Diagnostics AB (publ)

Name	Gross Profit	Gross Profit Difference
AroCell AB (publ)	-2.1 Million SEK	7145.671%
Immunovia AB (publ)	-5.1 Million SEK	2999.941%
Prostatype Genomics AB (publ)	-18.09 Million SEK	918.684%
SenzaGen AB	34.93 Million SEK	-323.967%
Spermosens AB	-169 Thousand SEK	87733.136%